Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Kahn

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|December 1, 1991
Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complexG Gatti, J O Kahn, J Lifson, et al.
Archives of Internal Medicine|January 14, 2004
Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virusSteven D Pinkerton, Jeffrey N Martin, Michelle E Roland, et al.
AIDS (London, England)|December 4, 2004
Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United StatesSteven D Pinkerton, Jeffrey N Martin, Michelle E Roland, et al.
AIDS Research and Human Retroviruses|December 22, 1999
Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccinationC P Locher, R M Grant, E A Collisson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2002
Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletionRonnie L Gascon, Amy B Narváez, Rongzhen Zhang, et al.
Blood|January 3, 2001
Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapyA M Schito, E Vittinghoff, F M Hecht, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trialJ O Kahn, L D Kaplan, P A Volberding, et al.
Inorganic Chemistry|February 24, 2001
Ferromagnetism in an extended three-dimensional, diamond-like copper(II) network: a new copper(II)/1-hydroxybenzotriazolato complex exhibiting soft-magnet properties and two transitions at 6.4 and 4.4 KV Tangoulis, C P Raptopoulou, V Psycharis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complexJ O Kahn, K J Gorelick, G Gatti, et al.
The Journal of Infectious Diseases|November 1, 1994
Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteersJ O Kahn, F Sinangil, J Baenziger, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|December 1, 1991
Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complexG Gatti, J O Kahn, J Lifson, et al.
Archives of Internal Medicine|January 14, 2004
Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virusSteven D Pinkerton, Jeffrey N Martin, Michelle E Roland, et al.
AIDS (London, England)|December 4, 2004
Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United StatesSteven D Pinkerton, Jeffrey N Martin, Michelle E Roland, et al.
AIDS Research and Human Retroviruses|December 22, 1999
Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccinationC P Locher, R M Grant, E A Collisson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2002
Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletionRonnie L Gascon, Amy B Narváez, Rongzhen Zhang, et al.
Blood|January 3, 2001
Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapyA M Schito, E Vittinghoff, F M Hecht, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trialJ O Kahn, L D Kaplan, P A Volberding, et al.
Inorganic Chemistry|February 24, 2001
Ferromagnetism in an extended three-dimensional, diamond-like copper(II) network: a new copper(II)/1-hydroxybenzotriazolato complex exhibiting soft-magnet properties and two transitions at 6.4 and 4.4 KV Tangoulis, C P Raptopoulou, V Psycharis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complexJ O Kahn, K J Gorelick, G Gatti, et al.
The Journal of Infectious Diseases|November 1, 1994
Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteersJ O Kahn, F Sinangil, J Baenziger, et al.
Pageof 9